• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型EG5抑制剂的合成与生物学评价

Synthesis and biological evaluation of novel EG5 inhibitors.

作者信息

Sarli Vasiliki, Huemmer Stefan, Sunder-Plassmann Nils, Mayer Thomas U, Giannis Athanassios

机构信息

University of Leipzig, Institute for Organic Chemistry, Johannisallee 29, 04103, Leipzig, Germany.

出版信息

Chembiochem. 2005 Nov;6(11):2005-13. doi: 10.1002/cbic.200500168.

DOI:10.1002/cbic.200500168
PMID:16216042
Abstract

Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.

摘要

人驱动蛋白Eg5是一种有丝分裂驱动蛋白,在有丝分裂过程中对双极纺锤体的形成和维持至关重要。最近,由于其作为下一代抗有丝分裂药物的潜在用途,能够抑制Eg5并导致有丝分裂停滞的化合物的发现引起了极大关注。在此,我们报道了3,4-二氢苯基喹唑啉-2(1H)-硫酮作为选择性强效Eg5抑制剂的合成及生物学研究。

相似文献

1
Synthesis and biological evaluation of novel EG5 inhibitors.新型EG5抑制剂的合成与生物学评价
Chembiochem. 2005 Nov;6(11):2005-13. doi: 10.1002/cbic.200500168.
2
New chemical tools for investigating human mitotic kinesin Eg5.用于研究人类有丝分裂驱动蛋白Eg5的新型化学工具。
Bioorg Med Chem. 2007 Oct 1;15(19):6474-88. doi: 10.1016/j.bmc.2007.06.016. Epub 2007 Jun 10.
3
Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.有丝分裂驱动蛋白Eg5抑制剂结合口袋的分子剖析揭示了对抗有丝分裂剂具有抗性的突变体。
J Mol Biol. 2006 Jul 7;360(2):360-76. doi: 10.1016/j.jmb.2006.04.062. Epub 2006 May 15.
4
Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.ADP 释放速率的显著下降是二甲奈醌抑制有丝分裂驱动蛋白 Eg5 和癌细胞增殖的强大活性的基础。
Biochem Biophys Res Commun. 2014 May 9;447(3):465-70. doi: 10.1016/j.bbrc.2014.04.023. Epub 2014 Apr 13.
5
Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.二氢嘧啶类抑制 Eg5 的结构基础:抗有丝分裂抑制剂恩曲他滨、二甲烯氟苯及氟他胺的立体选择性。
J Med Chem. 2010 Aug 12;53(15):5676-83. doi: 10.1021/jm100421n.
6
Identification of MAC1: A Small Molecule That Rescues Spindle Bipolarity in Monastrol-Treated Cells.MAC1的鉴定:一种能挽救经莫那可林处理的细胞纺锤体双极性的小分子。
ACS Chem Biol. 2016 Jun 17;11(6):1544-51. doi: 10.1021/acschembio.6b00203. Epub 2016 Apr 28.
7
Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.鉴定S-三苯甲基-L-半胱氨酸(一种有丝分裂驱动蛋白Eg5的新型强效抑制剂)的蛋白结合区域。
Biochemistry. 2004 Oct 19;43(41):13072-82. doi: 10.1021/bi049264e.
8
Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.有丝分裂驱动蛋白Eg5抑制剂monastrol与P-糖蛋白的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):291-9. doi: 10.1007/s00210-005-0022-5. Epub 2005 Dec 20.
9
Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.有丝分裂抑制剂monastrol与人类驱动蛋白Eg5的相互作用。
Biochemistry. 2003 Jan 21;42(2):338-49. doi: 10.1021/bi026716j.
10
Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5.有丝分裂驱动蛋白Eg5高效特异性抑制剂的研发及生物学评价
Chembiochem. 2005 Jul;6(7):1173-7. doi: 10.1002/cbic.200500005.

引用本文的文献

1
Clinically Applicable Inhibitors Impacting Genome Stability.影响基因组稳定性的临床适用抑制剂。
Molecules. 2018 May 13;23(5):1166. doi: 10.3390/molecules23051166.
2
The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells.驱动蛋白 Eg5 抑制剂 K858 诱导人胶质母细胞瘤细胞凋亡并逆转恶性侵袭表型。
Invest New Drugs. 2018 Feb;36(1):28-35. doi: 10.1007/s10637-017-0517-1. Epub 2017 Sep 30.
3
Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.
基于图像的药物分析计算预测协同药物组合:在三阴性乳腺癌中的应用。
Mol Oncol. 2014 Dec;8(8):1548-60. doi: 10.1016/j.molonc.2014.06.007. Epub 2014 Jun 19.
4
A non-motor microtubule binding site is essential for the high processivity and mitotic function of kinesin-8 Kif18A.非马达微管结合位点对于驱动蛋白-8 Kif18A 的高进程性和有丝分裂功能是必需的。
PLoS One. 2011;6(11):e27471. doi: 10.1371/journal.pone.0027471. Epub 2011 Nov 10.
5
Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction.Hippo 通路的组成部分与 Nek2 激酶合作调节中心体分离。
Nat Cell Biol. 2010 Dec;12(12):1166-76. doi: 10.1038/ncb2120. Epub 2010 Nov 14.
6
Essential genes for astroglial development and axon pathfinding during zebrafish embryogenesis.胚胎期斑马鱼星形胶质细胞发育和轴突寻路的必需基因。
Dev Dyn. 2010 Oct;239(10):2603-18. doi: 10.1002/dvdy.22393.
7
Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.使用新型Plk1抑制剂ZK-噻唑烷酮阐明Plk1在有丝分裂早期和晚期的功能。
Mol Biol Cell. 2007 Oct;18(10):4024-36. doi: 10.1091/mbc.e07-05-0517. Epub 2007 Aug 1.
8
Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.二聚体Eg5通过交替位点催化和限速ATP水解来维持持续合成能力。
J Biol Chem. 2006 Dec 22;281(51):39444-54. doi: 10.1074/jbc.M608056200. Epub 2006 Oct 23.